s-nitrosoglutathione has been researched along with Anasarca in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dhindsa, RK; Gilg, AG; Im, YB; Khan, M; Shunmugavel, A; Singh, AK; Singh, I | 1 |
| Bilgen, M; Chou, PC; Desouki, MM; El Sayed, H; Khan, M; Nguyen, SA; Shunmugavel, A; Singh, I | 1 |
2 other study(ies) available for s-nitrosoglutathione and Anasarca
| Article | Year |
|---|---|
Administration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact.
Topics: Animals; Apoptosis; Behavior, Animal; Blood-Brain Barrier; Brain; Brain Injuries; Edema; Humans; Macrophages; Male; Matrix Metalloproteinase 9; Microglia; Neuropsychological Tests; Nitric Oxide Synthase Type II; Oxidation-Reduction; Random Allocation; Rats; Rats, Sprague-Dawley; S-Nitrosoglutathione | 2009 |
Preclinical use of longitudinal MRI for screening the efficacy of S-nitrosoglutathione in treating spinal cord injury.
Topics: Administration, Oral; Animals; Drug Evaluation, Preclinical; Drug Monitoring; Edema; Female; Magnetic Resonance Imaging; Nervous System; Neuroprotective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; S-Nitrosoglutathione; Spinal Cord Injuries; Time Factors; Treatment Outcome | 2011 |